Rapid cognitive decline in Alzheimer's disease: a literature review

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Review of Psychiatry

• Publication date

  2013-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/09540261.2013.859128PMID 24423219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.

  2012cited by this paper
• Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database

  2011cited by this paper
• The influence of ApoE4 on clinical progression of dementia: a meta‐analysis

  2011cited by this paper
• Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

  2011cited by this paper
• Predicting progression of Alzheimer's disease

  2010cited by this paper
• Tackling age‐related disease: time for a step forward

  2010cited by this paper
• P3‐391: Statins for the treatment of dementia

  2010cited by this paper
• Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.

  2010influential reference
• Screening and assessment instruments for the detection and measurement of cognitive impairment

  2010cited by this paper
• A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T)

  2010cited by this paper
• Neuropsychological Predictors of Rapidly Progressing Patients with Alzheimer’s Disease

  2010influential reference
• Contribution of vascular risk factors to the progression in Alzheimer disease.

  2009influential reference
• Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

  2009cited by this paper
• Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease

  2009cited by this paper
• Cardiovascular Disease Risk Factors and Progression of Alzheimer’s Disease

  2009cited by this paper
• Age, neuropathology, and dementia.

  2009cited by this paper
• ate of MMSE score change in Alzheimer ’ s disease : nfluence of education and vascular risk factors

  2009cited by this paper
• Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors

  2009cited by this paper
• Rapid cognitive decline in Alzheimer's disease. Consensus paper

  2008cited by this paper
• APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease

  2008cited by this paper
• Smoking, dementia and cognitive decline in the elderly, a systematic review

  2008cited by this paper
• Whole-brain atrophy rate in Alzheimer disease

  2008cited by this paper
• Nutritional Status is Associated With Disease Progression in Very Mild Alzheimer Disease

  2008cited by this paper
• The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium

  2008cited by this paper
• Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

  2008cited by this paper
• Predictive Value of Rapid Decline in Mini Mental State Examination in Clinical Practice for Prognosis in Alzheimer’s Disease

  2008cited by this paper
• Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.

  2007cited by this paper
• Coexisting Cerebral Infarction in Alzheimer's Disease Is Associated with Fast Dementia Progression: Applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with

  2007cited by this paper
• Vascular factors predict rate of progression in Alzheimer disease

  2007cited by this paper
• Analysis of the Effect of Memantine in Reducing the Worsening of Clinical Symptoms in Patients with Moderate to Severe Alzheimer’s Disease

  2007cited by this paper
• Fast Cognitive Decline at the Time of Dementia Diagnosis: A Major Prognostic Factor for Survival in the Community

  2007cited by this paper
• Nursing home placement, day care use, and cognitive decline in Alzheimer's disease.

  2007cited by this paper
• Family history of dementia does not influence the progression of Alzheimer's disease at two years: Results from the REAL.FR Study

  2006cited by this paper
• Relationship of vascular risk to the progression of Alzheimer disease

  2006influential reference
• Vascular Disease and Risk Factors, Rate of Progression, and Survival in Alzheimer’s Disease

  2006cited by this paper
• Apolipoprotein E ε4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer’s Disease: Retrospective and Prospective Analysis

  2006cited by this paper
• Lipid lowering agents are associated with a slower cognitive decline in Alzheimer’s disease

  2005influential reference
• Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

  2005cited by this paper
• Prevalence of dementia in the elderly in Europe.

  2005cited by this paper
• Individual Growth Curve Analysis of APOE ε4–Associated Cognitive Decline in Alzheimer Disease

  2005cited by this paper
• Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

  2005cited by this paper
• APOE alleles predict the rate of cognitive decline in Alzheimer disease

  2005cited by this paper
• Rapid cognitive decline: searching for a definition and predictive factors among elderly with Alzheimer's disease.

  2005cited by this paper
• Education and rates of cognitive decline in incident Alzheimer’s disease

  2005cited by this paper
• The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.

  2005cited by this paper
• Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population

  2004cited by this paper
• Cognitive deterioration in Alzheimer’s disease: is the early course predictive of the later stages?

  2004cited by this paper
• Education and the course of cognitive decline in Alzheimer disease

  2004cited by this paper
• A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline

  2004cited by this paper
• Cholesterol and APOE genotype interact to influence Alzheimer disease progression

  2004cited by this paper
• Hypertension and the Rate of Cognitive Decline in Patients With Dementia of the Alzheimer Type

  2004cited by this paper
• Predicting the rate of cognitive decline in aging and early Alzheimer disease

  2004cited by this paper
• Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity.

  2003cited by this paper
• Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.

  2003cited by this paper
• The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.

  2003cited by this paper
• Accelerated Memory Decline in Alzheimer's Disease With Apolipoprotein ϵ4 Allele

  2003cited by this paper
• Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease

  2002cited by this paper
• Apolipoprotein E among Korean Alzheimer’s Disease Patients in Community-Dwelling and Hospitalized Elderly Samples

  2002cited by this paper
• Which Alzheimer Patients Are at Risk for Rapid Cognitive Decline?

  2002cited by this paper
• Rates of progression in mild cognitive impairment and early Alzheimer’s disease

  2002cited by this paper
• Effects of Educational Attainment and Occupational Status on Cognitive and Functional Decline in Persons With Alzheimer-Type Dementia

  2002cited by this paper
• Measuring Alzheimer’s disease progression with transition probabilities

  2001cited by this paper
• The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease.

  2001cited by this paper
• A method for estimating progression rates in Alzheimer disease.

  2001cited by this paper
• Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease.

  2000cited by this paper
• Modelling mini mental state examination changes in Alzheimer's disease.

  2000cited by this paper
• Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

  1998cited by this paper
• Prognostic Factors in Very Old Demented Adults: A Seven‐Year Follow‐Up From a Population‐Based Survey in Stockholm

  1998cited by this paper
• Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.

  1998cited by this paper
• Assessment of progression and prognosis in ‘possible’ and ‘probable’ Alzheimer's disease

  1998cited by this paper
• Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease

  1998cited by this paper
• Factors affecting the age of onset and rate of progression of Alzheimer’s disease

  1998influential reference
• Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia

  1998cited by this paper
• Differential Diagnosis of the Major Progressive Dementias and Depression in Middle and Late Adulthood: A Summary of the Literature of the Early 1990s

  1998cited by this paper
• Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.

  1997cited by this paper
• No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.

  1997cited by this paper
• Alzheimer's disease: clinical predictors of rates of intellectual decline--a prospective study.

  1997cited by this paper
• The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease

  1997cited by this paper
• Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.

  1996cited by this paper
• Predicting rate of cognitive decline in probable Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E genotype and rate of decline in probabole Alzheimer's disease

  1996cited by this paper
• Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease

  1996cited by this paper
• Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease

  1996cited by this paper
• Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease

  1996cited by this paper
• Apolipoprotein ϵ4 allele and disease progression in patients with late-onset Alzheimer's disease

  1995cited by this paper
• Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease.

  1995cited by this paper
• Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease

  1995cited by this paper
• Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.

  1995cited by this paper
• Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline.

  1995cited by this paper
• Age at onset of Alzheimer's disease

  1994cited by this paper
• A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

  1994cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1993cited by this paper
• Rate of Progression and Prognostic Factors in Alzheimer's Disease: A Prospective Study

  1993influential reference
• Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease

  1992cited by this paper
• Progression of Cognitive Impairment in Alzheimer's Disease

  1991influential reference
• Measurement and prediction of functional capacity in Alzheimer's disease

  1990cited by this paper
• Rapidly progressive Alzheimer's disease.

  1989cited by this paper
• Rate of Progression of Alzheimer's Disease

  1989cited by this paper
• Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease

  1988cited by this paper

• Microfluidics in neural extracellular vesicles characterization for early Alzheimer's disease diagnosis.

  2024cites this paper
• Risk Factors for Rapid Cognitive Decline in Amyloid-Negative Individuals Without Cognitive Impairment or With Early-Stage Cognitive Loss in Screening Tests

  2024cites this paper
• Computer-aided diagnosis of Alzheimer’s disease and neurocognitive disorders with multimodal Bi-Vision Transformer (BiViT)

  2024cites this paper
• Characteristics of Cognitive Function Changes and Related Factors in Individuals With Cognitive Impairment During the Pandemic of COVID-19: A Retrospective Chart Review Study

  2023cites this paper
• The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease

  2023cites this paper
• Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease

  2023cites this paper
• Prevalence and outcomes of rapidly progressive dementia: a retrospective cohort study in a neurologic unit in China

  2023cites this paper
• Midazolam alleviates cellular senescence in SH‐SY5Y neuronal cells in Alzheimer's disease

  2022cites this paper
• Rapidly progressive dementias — aetiologies, diagnosis and management

  2022cites this paper
• Global cognitive trajectory patterns in Alzheimer’s disease

  2022cites this paper
• Looking for navigation charts for the journey through dementia

  2021cites this paper
• Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease

  2021influential citation
• Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis

  2021cites this paper
• Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease

  2021cites this paper
• Cognitive Decline in Alzheimer’s Disease Is Not Associated with APOE

  2021cites this paper
• The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias

  2021cites this paper
• P.320 Assessing disease progression in Alzheimer's disease

  2020cites this paper
• MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice

  2020cites this paper
• Identi cation of and a Prediction Model for Cognitive Trajectories in Patients With Mild Cognitive Impairment Due to Alzheimer’s Disease

  2020cites this paper
• Hybrid simulation modelling for dementia care services planning

  2020cites this paper
• Predicting Alzheimer's disease based on survival data and longitudinally measured performance on cognitive and functional scales.

  2020cites this paper
• Role of Muscle Profile in Alzheimer’s Disease: A 3-Year Longitudinal Study

  2019cites this paper
• Patients Who Attend Alone at a First Memory Consultation: Are They a Specific Population,or Is It an Instance of Confounding Bias?

  2019cites this paper
• Rate of Cognitive Decline in Alzheimer’s Disease Stratified by Age

  2019cites this paper
• The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer’s Disease

  2019influential citation
• Proteomic analysis reveals the potential neuroprotective effects of tetramethylpyrazine dimer in neuro2a/APPswe cells

  2019cites this paper
• Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders

  2018cites this paper
• The role of hydrogen in Alzheimer’s disease

  2018cites this paper
• Predictors of Rapid Cognitive Decline in Patients with Mild-to-Moderate Alzheimer Disease: A Prospective Cohort Study with 12-Month Follow-Up Performed in Memory Clinics

  2018cites this paper
• The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease

  2018cites this paper
• The Role of p53 in Alzheimer’s Disease: Impact on Tau Pathology

  2018cites this paper
• Can Exercise Improve Cognitive Symptoms of Alzheimer's Disease?

  2018cites this paper
• Analyse de la morphologie des sillons corticaux et de l'activation microgliale dans la maladie d'Alzheimer : étude couplée en IRM, TEP-PiB et TEP-DPA

  2018influential citation
• Therapeutic effect of transmembrane TAT-tCNTF via Erk and Akt activation using in vitro and in vivo models of Alzheimer's disease.

  2018cites this paper
• Advance care planning and anticipatory decision making in patients with Alzheimer disease

  2018cites this paper
• Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes

  2018cites this paper
• Protective Effects of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Isolated from Averrhoa Carambola L. (Oxalidaceae) Roots on Neuron Apoptosis and Memory Deficits in Alzheimer's Disease

  2018cites this paper
• Risk Factors of Rapid Cognitive Decline in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

  2018cites this paper
• Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years

  2018cites this paper
• Impact and Prevention of Neurodegenerative Diseases in Society: Alzheimer and Parkinson

  2017influential citation
• The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database

  2017cites this paper
• Progression of Alzheimer’s Disease: A Longitudinal Study in Norwegian Memory Clinics

  2017influential citation
• Consensus‐based recommendations for the management of rapid cognitive decline due to Alzheimer's disease

  2017cites this paper
• Kognitive Störung mit zerebellärem Syndrom

  2017cites this paper
• MODELING DEMENTIA RISK , COGNITIVE CHANGE, PREDICTIVE RULES IN LONGITUDINAL STUDIES

  2016cites this paper
• Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease

  2016cites this paper
• Demographic and clinical characteristics related to cognitive decline in Alzheimer disease in China

  2016cites this paper
• Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease

  2016cites this paper
• Association Between Comorbidity Burden and Rapid Cognitive Decline in Individuals with Mild to Moderate Alzheimer's Disease

  2015cites this paper
• Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial

  2015cites this paper
• Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer’s disease

  2015cites this paper
• Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline

  2015influential citation
• Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation

  2015cites this paper
• Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease.

  2015cites this paper
• Relationship of nutritional factors to cognitive decline in the progression of dementia: The Cache County Dementia Progression Study

  2015cites this paper
• The role of medical comorbidities on the risk for severe dementia, institutionalization, and death in Alzheimer's disease: A popoulation study in Cache County, Utah

  2015cites this paper
• Recent advances in Alzheimer's disease all over the world

  2015cites this paper
• Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature

  2014cites this paper
• High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease

  2013cites this paper
• Cerebrospinal fluid β-amyloid1–42 correlates with rate of progression in Alzheimer’s disease

  2012influential citation
• Risk Factors for Disease Progression in Alzheimer's Disease

  2011cites this paper
• Long‐term progression of Alzheimer's disease in patients under antidementia drugs

  2011cites this paper
• Effects of n‐3 fatty acids on cognitive decline: A randomized, double‐blind, placebo‐controlled trial in stable myocardial infarction patients

  2011cites this paper
• Chapter 5 LOWER CEREBRAL BLOOD FLOW IS ASSOCIATED WITH FASTER COGNITIVE DECLINE IN ALZHEIMER ’ S DISEASE

  year unknowncites this paper